Imaging Biomarkers in Oncology Clinical Trials
Following on in my series of blog posts about imaging biomarkers and the recent BioClinica symposium, I wanted to share some insights provided by Ali Guermazi, MD (a consultant to BioClinica, who was...
View ArticleClinical Data Collection in Oncology Studies - Most Common Challenges
Creating a clinical data collection strategy for oncology studies within tight timelines can be extremely challenging. Clinical data managers often face particular issues with interpreting the...
View ArticleClik here to view.
Innovations in Medical Imaging Software offer New Trial Capabilities
One of the driving forces in medical imaging is the innovation that is taking place in medical imaging software. I previously wrote about this from the 2010 Radiological Society of North America...
View ArticleClik here to view.
3 Principles of Tumor Behavior and Biology
So just how did James Bond, Moby Dick and the London Natural History Museum teach me about oncology in clinical trials and tumor behavior? Here’s my story. As a child I loved wandering through the...
View ArticleClik here to view.
BioClinica Oncology Symposium - May 14th 2013
On Tuesday May 14th, BioClinica will be hosting an all-day complimentary oncology symposium as part of their annual User Conference. The symposium will take place at the Hyatt Regency at Penn’s Landing...
View ArticleClik here to view.
Monitoring Skeletal Integrity for Safer Diabetes Therapies
Last week, I attended the Phacilitate Leaders conference in Boston, which brought together scientific leaders, innovators, executives and regulators in the fields of Oncology, Inflammation and...
View ArticleClik here to view.
Big Data Analytics for Improved Cancer Treatments
The White House recently hosted a "Big Data" event to recognize new partnerships aimed at advancing our understanding and develop tools for big data analytics. One of these partnerships, between the...
View ArticleClik here to view.
Evolving Response Criteria for Tumor Evaluation in Oncology Clinical Trials
Rapid advances in imaging and cancer biomarkers are helping to shift treatments from cytotoxic to molecularly targeted therapies, necessitating modifications to conventional anatomical response...
View ArticleClik here to view.
Applying Tumor Response Criteria for Skin Cancer Trials
Skin cancer is the most common cancer type, affecting more than 2 million people annually in the US alone. Given the rising incidence of skin cancer, mostly attributable to UV exposure, there are a...
View ArticleClik here to view.
Strong Clinical Operations for Enhancing Oncology Trials: Benefits of an...
The landscape of oncology drug development continues to evolve with shortened clinical trials, expedited drug development processes and the use of combined clinical and medical imaging data for patient...
View ArticleClik here to view.
Leveraging Imaging Biomarkers to Improve Drug Development
Molecular Imaging – Valuable Drug Development ToolsClinicians need ways to better predict patient responsesThe estimated cost for developing a drug is approaching upwards of $5 Billion dollars with a...
View ArticleClinical Data Collection in Oncology Studies - Most Common Challenges
Creating a clinical data collection strategy for oncology studies within tight timelines can be extremely challenging. Clinical data managers often face particular issues with interpreting the...
View ArticleClik here to view.
Innovations in Medical Imaging Software offer New Trial Capabilities
One of the driving forces in medical imaging is the innovation that is taking place in medical imaging software. I previously wrote about this from the 2010 Radiological Society of North America...
View ArticleClik here to view.
3 Principles of Tumor Behavior and Biology
So just how did James Bond, Moby Dick and the London Natural History Museum teach me about oncology in clinical trials and tumor behavior? Here’s my story. As a child I loved wandering through the...
View ArticleClik here to view.
BioClinica Oncology Symposium - May 14th 2013
On Tuesday May 14th, BioClinica will be hosting an all-day complimentary oncology symposium as part of their annual User Conference. The symposium will take place at the Hyatt Regency at Penn’s Landing...
View ArticleClik here to view.
Monitoring Skeletal Integrity for Safer Diabetes Therapies
Last week, I attended the Phacilitate Leaders conference in Boston, which brought together scientific leaders, innovators, executives and regulators in the fields of Oncology, Inflammation and...
View ArticleClik here to view.
Big Data Analytics for Improved Cancer Treatments
The White House recently hosted a "Big Data" event to recognize new partnerships aimed at advancing our understanding and develop tools for big data analytics. One of these partnerships, between the...
View ArticleClik here to view.
Evolving Response Criteria for Tumor Evaluation in Oncology Clinical Trials
Rapid advances in imaging and cancer biomarkers are helping to shift treatments from cytotoxic to molecularly targeted therapies, necessitating modifications to conventional anatomical response...
View ArticleClik here to view.
Applying Tumor Response Criteria for Skin Cancer Trials
Skin cancer is the most common cancer type, affecting more than 2 million people annually in the US alone. Given the rising incidence of skin cancer, mostly attributable to UV exposure, there are a...
View ArticleClik here to view.
Strong Clinical Operations for Enhancing Oncology Trials: Benefits of an...
The landscape of oncology drug development continues to evolve with shortened clinical trials, expedited drug development processes and the use of combined clinical and medical imaging data for patient...
View Article
